• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链脲佐菌素诱导的糖尿病大鼠的肾肥大

Renal hypertrophy in streptozotocin-diabetic rats.

作者信息

Seyer-Hansen K

出版信息

Clin Sci Mol Med. 1976 Dec;51(6):551-5. doi: 10.1042/cs0510551.

DOI:10.1042/cs0510551
PMID:137797
Abstract
  1. Kidney weight and content of protein, RNA and DNA were measured in rats with streptozotocin diabetes of varying duration. 2. Diabetic rats had larger kidneys than control rats: after 3 days of diabetes the weight increase was 15 per cent and after 42 days of diabetes it was 90 per cent. The protein content rose in parallel to the weight. 3 RNA content was already increased after 36 h of glycosuria, whereas DNA content was unchanged for the first 3 days of diabetes, and increased thereafter. The protein/DNA ratio increased rapidly during the first 3 days but remained constant thereafter. 4. Insulin treatment decreased the renal weight gain by about 67 per cent during the first 8 days of diabetes, but did not prevent the increase in DNA. When insulin was started after 25 days of diabetes there was only a slight regression of kidney growth.
摘要
  1. 对患有不同病程链脲佐菌素糖尿病的大鼠测量了肾脏重量以及蛋白质、RNA和DNA的含量。2. 糖尿病大鼠的肾脏比对照大鼠的大:糖尿病3天后体重增加15%,糖尿病42天后体重增加90%。蛋白质含量与体重平行上升。3. 糖尿36小时后RNA含量就已增加,而糖尿病最初3天DNA含量未变,此后增加。蛋白质/DNA比值在最初3天迅速增加,但此后保持恒定。4. 胰岛素治疗在糖尿病的前8天使肾脏重量增加减少约67%,但并未阻止DNA增加。糖尿病25天后开始使用胰岛素时,肾脏生长仅有轻微消退。

相似文献

1
Renal hypertrophy in streptozotocin-diabetic rats.链脲佐菌素诱导的糖尿病大鼠的肾肥大
Clin Sci Mol Med. 1976 Dec;51(6):551-5. doi: 10.1042/cs0510551.
2
Renal hypertrophy in experimental diabetes: relation to severity of diabetes.实验性糖尿病中的肾肥大:与糖尿病严重程度的关系。
Diabetologia. 1977 Apr;13(2):141-3. doi: 10.1007/BF00745142.
3
Tubular cell protein degradation in early diabetic renal hypertrophy.
J Am Soc Nephrol. 1994 Feb;4(8):1582-7. doi: 10.1681/ASN.V481582.
4
Renal hypertrophy in experimental diabetes: a comparison to compensatory hypertrophy.实验性糖尿病中的肾肥大:与代偿性肥大的比较。
Diabetologia. 1978 May;14(5):325-8. doi: 10.1007/BF01223024.
5
The effects of pentoxifylline on diabetic renal changes in streptozotocin-induced diabetes mellitus.己酮可可碱对链脲佐菌素诱导的糖尿病中糖尿病性肾脏改变的影响。
Ren Fail. 2004 Nov;26(6):597-605. doi: 10.1081/jdi-200038329.
6
Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats.链脲佐菌素诱导的糖尿病大鼠胰岛素治疗后肾肥大及肾钠钾ATP酶活性升高的消退
Endocrinology. 1987 May;120(5):2166-73. doi: 10.1210/endo-120-5-2166.
7
Renal hypertrophy in experimental diabetes. A morphometric study.实验性糖尿病中的肾肥大。一项形态计量学研究。
Diabetologia. 1980 Jun;18(6):501-5. doi: 10.1007/BF00261707.
8
Effect of vanadate on renal hypertrophy and sorbitol accumulation in streptozotocin induced diabetes in rats.钒酸盐对链脲佐菌素诱导的大鼠糖尿病肾肥大和山梨醇蓄积的影响。
Res Commun Chem Pathol Pharmacol. 1991 May;72(2):191-202.
9
Epidermal growth factor in renal hypertrophy in streptozotocin-diabetic rats.表皮生长因子与链脲佐菌素诱导的糖尿病大鼠肾肥大
Nephron. 1991;59(4):641-7. doi: 10.1159/000186658.
10
Renal proteinases and kidney hypertrophy in experimental diabetes.实验性糖尿病中的肾蛋白酶与肾肥大
Diabetologia. 1994 Jun;37(6):567-71. doi: 10.1007/BF00403374.

引用本文的文献

1
Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct.恩格列净会使肾脏重量增加,这是由于近端小管S3段和集合管中的细胞体积增大所致。
Front Pharmacol. 2023 Mar 23;14:1118358. doi: 10.3389/fphar.2023.1118358. eCollection 2023.
2
Histone Deacetylase Inhibitors and Diabetic Kidney Disease.组蛋白去乙酰化酶抑制剂与糖尿病肾病。
Int J Mol Sci. 2018 Sep 5;19(9):2630. doi: 10.3390/ijms19092630.
3
Calcium dobesilate may alleviate diabetes‑induced endothelial dysfunction and inflammation.
羟苯磺酸钙可能缓解糖尿病引起的内皮功能障碍和炎症。
Mol Med Rep. 2017 Dec;16(6):8635-8642. doi: 10.3892/mmr.2017.7740. Epub 2017 Oct 9.
4
An early diagnostic tool for diabetic peripheral neuropathy in rats.一种用于大鼠糖尿病周围神经病变的早期诊断工具。
PLoS One. 2015 May 18;10(5):e0126892. doi: 10.1371/journal.pone.0126892. eCollection 2015.
5
C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat.C 肽可保护链脲佐菌素诱导的糖尿病大鼠的肾脏微血管结构。
J Diabetes Complications. 2013 Nov-Dec;27(6):538-47. doi: 10.1016/j.jdiacomp.2013.07.002. Epub 2013 Aug 29.
6
Apelin retards the progression of diabetic nephropathy.Apelin 可延缓糖尿病肾病的进展。
Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F788-800. doi: 10.1152/ajprenal.00306.2012. Epub 2013 Jan 9.
7
Protective effect of herbomineral formulation (Dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats.草药矿物配方(Dolabi)对链脲佐菌素诱导的糖尿病大鼠早期糖尿病肾病的保护作用。
J Nat Med. 2012 Jul;66(3):500-9. doi: 10.1007/s11418-011-0614-y. Epub 2011 Nov 25.
8
The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels.链脲佐菌素诱导的成年糖尿病大鼠肾脏中胰岛素样生长因子-I(IGF-I)的蓄积与血浆生长激素(GH)或IGF-I水平升高无关。
Endocrine. 1995 Sep;3(9):689-93. doi: 10.1007/BF02746346.
9
Effect of in vitro glucose and diabetic hyperglycemia on mouse kidney protein synthesis: relevance to diabetic microangiopathy.体外葡萄糖和糖尿病高血糖对小鼠肾脏蛋白质合成的影响:与糖尿病微血管病变的相关性。
MedGenMed. 2005 Sep 7;7(3):1.
10
Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction.链脲佐菌素诱导的糖尿病持续时间对肾脏和血管功能障碍中p38丝裂原活化蛋白激酶(MAPK)磷酸化有不同影响。
Cardiovasc Diabetol. 2005 Mar 5;4:3. doi: 10.1186/1475-2840-4-3.